Ovarian Cancer Diagnostics Market Growing with Advanced Technology Developments
Global Ovarian Cancer Diagnostics Market is anticipated
to grow with increasing instances of ovarian cancer in female population.
According to TechSci Research report, “Ovarian
Cancer Diagnostics Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, 2017-2027”, the global ovarian
cancer diagnostics market is bound to expand in the forecast years with
impressive CAGR due to surge in the demands for the early diagnosis of ovarian
cancer from the population. Increasing instances of ovarian cancer along with
the advancing healthcare services further drive the growth of the global
ovarian cancer diagnostics market in the upcoming five years. Among other types
of gynecological cancers, ovarian cancer has the largest patient pool suffering
from the diseases in past few years. Higher mortality rate and increasing
threat due to various environmental factors and genetic mutations further
support the growth of the global ovarian cancer diagnostics market in the next
five years. Some of the generic symptoms of the disease include bloating,
abnormal menstruation, vaginal bleeding, indigestion, etc. although these
symptoms are not definitive for the diseases and patients with family history
of the disease must regularly get diagnostic tests done to ensure early
diagnosis and better treatment.
Demand for the research and technological advancement has enhanced due
to growing demands for the early diagnosis but the diseases is only identified
at the advanced stage. With better techniques and advancement in the diagnostic
tests the identification may improve that would further facilitate the growth
of the global ovarian cancer diagnostics market in the future five years. The
government is making efforts toward the situation. Increasing number of
initiatives, investments in the healthcare sector to advance the services along
with favorable schemes for the promotion of further studies over ovarian cancer
is also anticipated to substantiate the growth of the global ovarian cancer
diagnostics market in the forecast years through 2027.
Browse over XX market
data Figures spread through 110 Pages and an
in-depth TOC on "Global Ovarian Cancer Diagnostics Market"
https://www.techsciresearch.com/report/ovarian-cancer-diagnostics-market/9494.html
The global ovarian cancer diagnostics market segmentation is based on
diagnosis type, cancer type, end user, regional distribution, and competitive
landscape. Based on diagnosis type, the market is further segmented into
diagnostic imaging, blood test, biopsy, and others. Diagnostic imaging includes
transvaginal ultrasound, CT scan, MRI scan, pet scan, and others. Blood tests
include CA-125, HER2, BRCA, KRAS mutation, and others. Biopsy includes image
guided biopsy, fine needle aspiration biopsy, and others. By cancer type, the
market is fragmented into epithelial tumor, germ cell tumor, stromal cell
tumor, and others. Diagnostic imaging is anticipated to hold the largest
revenue shares of the market and dominate the market segment in the upcoming
five years on grounds of increasing importance of early diagnosis and cancer
staging. Transvaginal ultrasound is the preliminary technique that visualizes
the inner tumors and calculates the size of it. CT scans are also used for the
identification of the tumor cells, but the applications are limited and further
advancement in the technology is demanded that would fuel the growth of the
segment as well as the growth of the global ovarian cancer diagnostics market
in the future five years. Based on end user, the market is bifurcated into
hospitals & specialty clinics, ambulatory care centers, and others.
Some of the market players, dominating the global ovarian cancer
diagnostics market are:
·
Abbott Laboratories, Inc.
·
Bio-Rad Laboratories, Inc.
·
Quest Diagnostics, Inc.
·
Siemens Healthineers AG
·
Thermo Fischer Scientific, Inc.
·
F. Hoffmann-La Roche Ltd (Foundation Medicine)
·
MiRXES Pte Ltd
·
GinaLife
·
Luminex Corporation
·
Myriad Genetics Inc.
Download Sample Report @
https://www.techsciresearch.com/sample-report.aspx?cid=9494
Customers can also request for 10% free customization on this report.
“North America is anticipated to lead the revenue shares growth
of the market in the upcoming five years on the account of strong commercial
performances of gynecologic diagnostics in the US. Favorable government
initiatives, growing advancement in the technology coupled with increasing
healthcare expenditures is anticipated to further facilitate the growth of the
global ovarian cancer diagnostics market in the future five years. Increasing
number of market players invested in the market and advancing their technology
with growing investment in the research and development sector would also aid
the market growth. Asia Pacific region may hold fastest growing CAGR on the
backbone of overall economic development, improvement in the healthcare
infrastructure, increasing disposable income among the population and their
growing tendency to seek advanced healthcare services further substantiate the
growth of the global ovarian cancer diagnostics market in the forecast years,”
said Mr. Karan Chechi, Research Director with TechSci Research, a research
based global management consulting firm.
“Ovarian
Cancer Diagnostics Market - Global Industry Size, Share, Trends, Opportunity,
and Forecast, 2017-2027 Segmented By Diagnosis Type (Diagnostic Imaging
{Transvaginal Ultrasound, CT Scan, MRI Scan, PET Scan, Others}, Blood Test
{CA-125, HER2, BRCA, KRAS Mutation, Others}, Biopsy {Image Guided Biopsy, Fine
Needle Aspiration Biopsy, Others}, Others), By Cancer Type (Epithelial Tumor,
Germ Cell Tumor, Stromal Cell Tumor, Others), By End User (Hospitals &
Specialty Clinics, Ambulatory Care Centers, Others), By Region”, has evaluated the future growth
potential of global ovarian cancer diagnostics and provides statistics &
information on market size, structure, and future market growth. The report
intends to provide cutting-edge market intelligence and help decision makers
take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in global ovarian cancer diagnostics market.
Contact
Mr.
Ken Mathews
708
Third Avenue,
Manhattan,
NY,
New
York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com